Cargando…
Semisynthetic Pneumococcal Glycoconjugate Nanovaccine
[Image: see text] Pneumococcal conjugate vaccines offer an excellent safety profile and high protection against the serotypes comprised in the vaccine. However, inclusion of protein antigens fromStreptococcus pneumoniaecombined with potent adjuvants and a suitable delivery system are expected to bot...
Autores principales: | Prasanna, Maruthi, Varela Calvino, Rubén, Lambert, Annie, Arista Romero, Maria, Pujals, Sylvia, Trottein, François, Camberlein, Emilie, Grandjean, Cyrille, Csaba, Noemi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515484/ https://www.ncbi.nlm.nih.gov/pubmed/37694903 http://dx.doi.org/10.1021/acs.bioconjchem.3c00252 |
Ejemplares similares
-
Site-Specific Conjugation for Fully Controlled Glycoconjugate Vaccine Preparation
por: Pillot, Aline, et al.
Publicado: (2019) -
Development of an Efficacious, Semisynthetic Glycoconjugate
Vaccine Candidate against Streptococcus pneumoniae Serotype 1
por: Schumann, Benjamin, et al.
Publicado: (2018) -
Semisynthetic Glycoconjugate
Vaccine Candidates against Escherichia coli O25B Induce Functional IgG Antibodies
in Mice
por: Naini, Arun, et al.
Publicado: (2022) -
Conjugation Mechanism for Pneumococcal Glycoconjugate Vaccines: Classic and Emerging Methods
por: Morais, Victor, et al.
Publicado: (2022) -
Sequential Linkage of Carbohydrate Antigens to Mimic
Capsular Polysaccharides: Toward Semisynthetic Glycoconjugate Vaccine
Candidates against Streptococcus pneumoniae Serotype
14
por: Seco, Bruna M. S., et al.
Publicado: (2020)